Remove Atrial Fibrillation Remove Embolism Remove Thrombosis
article thumbnail

Study Demonstrates Abelacimab Significantly Reduced Bleeding in Patients Regardless of Age, Bleeding Risk

DAIC

Patients with atrial fibrillation, particularly older patients, are frequently at a high risk of bleeding. In patients with atrial fibrillation, abelacimab reduced rates of bleeding relative to rivaroxaban regardless of bleeding risk, with greater absolute safety benefit in those at higher bleeding risk.

article thumbnail

Management of complications associated with percutaneous left atrial appendage closure with or without ablation: experience from 512 cases over a 4-year period

Frontiers in Cardiovascular Medicine

BackgroundPercutaneous left atrial appendage closure (LAAC) serves as an alternative prophylactic strategy for patients with non-valvular atrial fibrillation (AF) who cannot undergo anti-coagulation therapy. The pericardial effusion or tamponade likely resulted from damage to the atrial appendage during LAAC device insertion.

article thumbnail

Efficacy and Safety of Low?Dose Edoxaban by Body Weight in Very Elderly Patients With Atrial Fibrillation: A Subanalysis of the Randomized ELDERCARE?AF Trial

Journal of the American Heart Association

The primary efficacy and safety end points were stroke or systemic embolism and major bleeding (International Society on Thrombosis and Hemostasis definition), respectively. The stroke or systemic embolism rate was lower with edoxaban than placebo in both weight groups (≤45 kg: hazard ratio [HR], 0.36 [95% CI, 0.16–0.80];

article thumbnail

MP-483492-002 COMPARATIVE EFFECTIVENESS OF DIFFERENT MANAGEMENT STRATEGIES FOR LEFT ATRIAL APPENDAGE THROMBUS IN PATIENTS ON OPTIMAL NOAC THERAPY

HeartRhythm

Left atrial appendage (LAA) thrombus is the primary cause of stroke and systemic embolism in atrial fibrillation (AF). Novel oral anticoagulants (NOACs) effectively reduce the prevalence of LAA thrombosis and stroke risk.

article thumbnail

Abstract WP328: Higher Artificial Intelligence (AI)-ECG Atrial Fibrillation Prediction Model Output and Delta Age Computed from AI-ECG are Associated with Adverse Vascular Outcomes in Patients with Migraine

Stroke Journal

AI-ECG prediction models developed at our institution can evaluate the probability of atrial fibrillation (AF) and estimate a patients age based on a normal sinus rhythm (NSR) ECG. Migraine with aura(MwA) is associated with an increased risk of stroke and adverse vascular outcomes compared to those with migraine without aura (MwoA).

article thumbnail

Abstract TMP43: Age, Race, and Insurance Status Influences on Anticoagulation Therapy and Discharge Disposition: A Retrospective Analysis

Stroke Journal

Patients were drawn from neurology, cardiology, and other services. Descriptive statistics were used to compare trends across these groups.Results:Of the 3,966 patients, AF was the most common diagnosis (47.16% self-pay, 67.14% insured), followed by DVT and PE.

article thumbnail

A man in his 30s with cardiac arrest and STE on the post-ROSC ECG

Dr. Smith's ECG Blog

The rhythm is atrial fibrillation. As in all ischemia interpretations with OMI findings, the findings can be due to type 1 AMI (example: acute coronary plaque rupture and thrombosis) or type 2 AMI (with or without fixed CAD, with severe regional supply/demand mismatch essentially equaling zero blood flow).